Smartleaf Asset Management’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.78K Hold
345
– – ﹤0.01% 2771
2026
Q1
$2.67K Hold
345
– – ﹤0.01% 2882
2025
Q4
$3.53K Buy
+345
New +$3.62K ﹤0.01% 2819
2025
Q2
– Sell
-17
Closed -$119 – 2870
2025
Q1
$119 Sell
17
-94
-85% -$733 ﹤0.01% 2836
2024
Q4
$944 Sell
111
-121
-52% -$1.74K ﹤0.01% 2682
2024
Q3
$4.53K Buy
232
+47
+25% +$952 ﹤0.01% 2168
2024
Q2
$3.79K Buy
+185
New +$3.8K ﹤0.01% 1938

Other funds holding KURA

Smartleaf Asset Management's KURA Position: Q2 2026 in Review

Smartleaf Asset Management held its Kura Oncology (KURA) position steady in Q2 2026 at 345 shares worth $3.78K. The position accounts for ﹤0.01% of the portfolio, ranked #2771.

Smartleaf Asset Management first reported a position in KURA in Q2 2024 and has held it in 7 quarters since. The position peaked at $4.53K in Q3 2024. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Smartleaf Asset Management held 345 shares of Kura Oncology worth $3.78K as of Q2 2026.
  • Smartleaf Asset Management left its Kura Oncology share count unchanged in Q2 2026.
  • Kura Oncology made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #2771 holding.
  • Smartleaf Asset Management first reported a position in Kura Oncology in Q2 2024 and has held it in 7 quarters since.
  • Smartleaf Asset Management's Kura Oncology position peaked at $4.53K in Q3 2024.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.